Read more

January 13, 2024
1 min read
Save

Project has moonshot goal of curing blindness through whole eye transplantation

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

WAILEA, Hawaii — The Advanced Research Projects Agency for Health has launched a program to restore vision through the transplantation of whole human eyes, according to a speaker here.

In a presentation at Hawaiian Eye/Retina 2024, Calvin Roberts, MD, program manager for the Transplantation of Human Eye Allografts (THEA) program, described transplanting a human eye as being comparable to “transplanting a piece of brain.”

Eye and brain
The Advanced Research Projects Agency for Health has launched a program to restore vision through the transplantation of whole human eyes, according to a speaker here.
Image: Adobe Stock

“The goal for the THEA program is to restore vision for people who are blind through whole eye transplantation by developing new technologies to regrow the nerves from the eye to the brain,” Roberts said.

Calvin Roberts, MD
Calvin Roberts

According to Roberts, the THEA program will focus on three key areas of research to achieve the final goal of whole eye transplantation: retrieval and preservation of donor eyes; optic nerve repair and regeneration and surgical techniques, immunology and postoperative monitoring.

“We’re at the point now where we are looking to find performers — people who can do this work,” he said.

The THEA program has identified multiple strategies to spur nerve regrowth as a part of optic nerve reattachment and repair. These strategies, Roberts explained, include using nerve wraps on the two ends of the optic nerve, promoting nerve growth through electrical stimulation, replacing lost cells with stem-cell derived retinal ganglion cells and using neuroprotection to preserve retinal ganglion cells.

Roberts invited ophthalmologists who are interested in getting involved with the project to visit arpa-h.gov for more information.

“There's a lot to be done, and we want you to join us,” he concluded. “Come be a part of this.”